mCig, Inc. to Sponsor Booth at SoCal High Times(R) Medical Cannabis Cup(TM); Company Brand Ambassador and Hip Hop Recording Legend, Rick Ross to Perform
BEVERLY HILLS, Calif., Jan. 23, 2015 (GLOBE NEWSWIRE) — mCig(R) Inc. (MCIG), a technology company that owns, manufactures, and distributes the mCig(R), VitaCig(R), and Vapolution products, is pleased to announce the company will be highlighting their line of vaporizers and consumer accessories at the SoCal High Times(R) Medical Cannabis Cup(TM), Feb. 7th and 8th, 2015. The company’s Brand Ambassador, Rick Ross, will be performing on Feb. 7th at the opening night event for show attendees.
In addition to the company’s best-selling 3.0, new 4.0, and Rick Ross BO$S models of portable vaporizers, mCig, Inc. will be highlighting a number of new breakthrough Cannabis-related consumer products in a large 20×20 booth at the weekend Cannabis Cup. Some of the products being unveiled will carry the “Made in America” distinction and are considered to be industry game changers.
These are among the first products designed and engineered by mCig’s new Chief Research and Development Officer, Mike Snody. According to mCig, Inc.’s Director and Chief Operating Officer Mark Linkhorst, the products being unveiled at the Southern California Cannabis Cup all reflect a design aesthetic previously not seen in the industry.
“The medical and recreational marijuana accessories industry offers a multi-million-dollar opportunity for top-of-design products that resonate with consumers. With the addition of Mike Snody to our executive team, we’ve got a master product designer at the helm creating unique products that truly are distinguished from the competition in both form and function. These new grinders really underscore the company’s future product direction,” explained Linkhorst.
This event marks the first in a series of cannabis industry events that mCig, Inc. is sponsoring. The Medical Cannabis Cup(TM) will have 25000 attendees and be held at the NOS Events Center in San Bernardino. The event attracts vendors, buyers, retailers and consumers along with multiple educational seminars featuring medical cannabis therapeutics, cultivation, concentrate and edible preparations, highlighted by the Medical Cannabis Cup(TM) Awards.
mCig, Inc. also plans to promote its new line of products and accessories via ad campaigns to be featured in High Times(R) magazine as well as online properties in the coming months, beginning with the special 4/20 Issue due out in the next few weeks.
About mCig, Inc.
mCig, Inc. (MCIG) is a technology company focused on two long-term secular trends sweeping the globe: (1) The decriminalization and legalization of marijuana for medicinal or recreational purposes (2) The adoption of electronic vaporizing cigarettes (commonly known as “eCigs”) by the world’s 1.2 Billion smokers. The company believes that a well-regulated marijuana industry is emerging as more states follow the lead of Alaska, Colorado, Oregon, and Washington in legalizing marijuana. A similar trend is developing within the eCig industry following the first acquisition of an electronic cigarette brand (Blucigs) by a traditional tobacco company Lorillard Inc. for $135 million followed by another acquisition in February 2014 by Altria Group Inc. of Green Smoke for $150 million. Wells Fargo analyst Bonnie Herzog estimates that eCig sales may rise from $1 Billion in 2013 to $10 billion over the next three years.
Safe Harbor Statement
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company’s ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company’s products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company’s business, research, product development, regulatory approval, marketing and distribution plans and strategies.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | firstname.lastname@example.org